protein drugs Flashcards

1
Q

examples of targets for 30S ribosome

A

tetracyclins, streptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

example of targets for the 50S ribosome

A

chloramphenicol, erythromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

action of spectinomycin

A

interferes with elongation factor G during translocation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

action of paramomycin and streptomycin

A

bind to 30S subunit near the A site for tRNA binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

initiation of protein synthesis in bacteria

A
  • first N-terminal AA = formylmethionine
  • mRNA becomes attached to 30S which requires participation of a soluble protein, initiation factor 3
  • formylmethionine-charged tRNA combines with mRNA-30S ribosomal complex, which requires initiation factors 1 and 2 and GTP
  • 50S ribosomal unit becomes bound > GTP hydrolysed > initiation factors released
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

elongation phase of protein synthesis in bacteria

A

2 of these require elongation factors & GTP:
- first 2 tRNAs orient appropriately, with attached AAs adjacent on the surface of the 50S portion of the ribosomes
- they become linked by a peptide bond by the peptidyltransferase activity associated with the 50S subunit
- carboxyl group of formylmethionine is linked to the amino group of the 2nd AA, and the dipeptide is attached to the 2nd tRNA, occupying the A site
- tRNA for formylmethionine moves from P to E site and is released. tRNA with dipeptide moves from A to P site and the 30S subunit moves one codon along the mRNA
- continues until a termination sequence signals that protein is complete

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

tetracycline action

A
  • oxygens of internucleotide phosphodiester links in 16S rRNA form electrostatic interactions directed through a Mg2+ ion to the bottom edge of tetracycline
  • it blocks rotation of aminoacyl-tRNA into the A site
  • so the aminoacyl-tRNA is prematurely released and the cycle is terminated without peptide bond formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

aminoglycoside action

A
  • bind to 30S ribosomal subunit and freeze the pre-initiation complex (subunit, mRNA and fmet-tRNA) so no further initiation can occur
  • also slow protein synthesis that’s already been initiated and induce misreading of mRNA (so bactericidal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

example of expanded spectrum macrolide

A

clarithromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

action of erythromycin & clarithromycin

A
  • bind at entrance to export tunnel of 50S subunit and interact with 23S rRNA
  • so there’s a 6-8 oligopeptidyl-tRNA buildup before elongation is blocked and prematurely terminated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

lincomycin action

A

direct peptidyltransferase inhibitor (so competitive with macrolides)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which antibiotics bind to 23S rRNA in overlapping binding sites

A
  • macrolides
  • lincosamides (e.g. lincomycin)
  • streptogramin B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

clindamycin action

A
  • direct peptidyltransferase inhibitor
  • interacts with A and P sites of peptidyltransferase centre, competing w the binding of loaded tRNA molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

chloramphenicol action

A

binds to 50S ribosomal subunit near the A site, preventing peptidyltransferase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

fusidic action

A

also binds to and inhibits elongation factor G, blocking translocation - but better because less side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

synercid action

A
  • binds to 23S rRNA sites partially overlapping with those targeted by macrolides
  • synergistic nonribosomal peptide combination (quinupristin + dalfopristin) which blocks polypeptide translocation @ 50S